M
MedgenLife Science
NMPA Class III Medical Device

BoneSwift™

China's First Pre-filled Injectable Bone Repair Material

Overview

BoneSwift™ is a revolutionary pre-filled injectable bone repair material designed for minimally invasive orthopedic procedures. As China's first pre-filled bone repair product, it streamlines surgical workflow and improves patient outcomes through advanced biomaterial technology.

Approved Indications

Limb bone defect filling — non-load-bearing or low-load-bearing
Spinal bone defect repair — approved August 2025

Key Features

  • Pre-filled syringe design — ready to use, no mixing required
  • Excellent injectability for minimally invasive delivery
  • High-viscosity moldable body, 360° conformity to bone defects
  • Natural trabecular bone structure retained from porcine cancellous bone
  • Material degradation synchronized with bone metabolism cycle
  • Room temperature storage — no special handling needed

Biological Performance

  • Simulates human bone microenvironment
  • Excellent osteoinductive properties, comparable to autologous bone
  • Promotes osteoblast proliferation and differentiation
  • Accelerates bone tissue regeneration
  • Post-operative 6-week bone tissue induction volume is 2× that of competing products

Clinical Applications

Limb bone defect filling (non-load-bearing or low-load-bearing)
Spinal bone defect repair
Trauma surgery bone void filling
Revision joint replacement

Regulatory & Certifications

China2024-12

NMPA Class III

Limb bone defect filling

China2025-08

NMPA Class III

Spinal bone defect filling

Vietnam2025-12

Class D (highest)

Articles & Evidence

Clinical Evidence

First installment of the BoneSwift™ injectable bone graft material clinical case series for limb bone defect repair, showcasing real-world clinical applications.

2 min readRead More

Second installment of the BoneSwift™ injectable bone graft material clinical case series for limb bone defect repair, highlighting product handling and intraoperative performance.

1 min readRead More

First installment of the BoneSwift™ injectable bone graft material clinical case series for spinal bone defect repair, showcasing clinical applications in spinal surgery.

1 min readRead More

Product Features

Medgen's independently developed BoneSwift™, China's first pre-filled injectable artificial bone, has completed all clinical trial subject follow-ups, with safety and efficacy fully validated.

3 min readRead More

Approvals & Launches

Medgen Life Science's BoneSwift™ receives NMPA Class III certification as China's first hydroxyapatite pre-filled bone repair material, offering ready-to-use convenience and enhanced surgical efficiency.

2 min readRead More

Medgen's independently developed BoneSwift™ pre-filled injectable bone filling material receives Class D medical device registration from Vietnam's Ministry of Health, the highest risk classification in Vietnam's regulatory system.

2 min readRead More

Interested in BoneSwift™?

Contact our team to learn more about BoneSwift™ and how it can benefit your clinical practice.

Also explore